vs

Side-by-side financial comparison of DYNEX CAPITAL INC (DX) and OptimizeRx Corp (OPRX). Click either name above to swap in a different company.

DYNEX CAPITAL INC is the larger business by last-quarter revenue ($43.5M vs $32.2M, roughly 1.3× OptimizeRx Corp). On growth, DYNEX CAPITAL INC posted the faster year-over-year revenue change (531.3% vs -0.2%). Over the past eight quarters, DYNEX CAPITAL INC's revenue compounded faster (75.8% CAGR vs 28.0%).

Dynex Capital Inc. is a publicly traded real estate investment trust headquartered in the United States. It specializes in investing in and managing a diversified portfolio of mortgage-backed securities, residential and commercial mortgage loans, and other mortgage-related assets. It delivers consistent returns to shareholders via regular dividends and long-term capital growth.

OptimizeRx Corp is a U.S.-headquartered digital health technology company that delivers patient engagement, medication affordability and clinical communication solutions to life sciences enterprises, healthcare providers and pharmacy partners. Its core offerings include digital medication savings tools, patient support programs, and therapeutic area-specific resources to boost medication access and treatment adherence.

DX vs OPRX — Head-to-Head

Bigger by revenue
DX
DX
1.3× larger
DX
$43.5M
$32.2M
OPRX
Growing faster (revenue YoY)
DX
DX
+531.5% gap
DX
531.3%
-0.2%
OPRX
Faster 2-yr revenue CAGR
DX
DX
Annualised
DX
75.8%
28.0%
OPRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DX
DX
OPRX
OPRX
Revenue
$43.5M
$32.2M
Net Profit
$5.0M
Gross Margin
74.8%
Operating Margin
26.6%
Net Margin
15.6%
Revenue YoY
531.3%
-0.2%
Net Profit YoY
6535.9%
EPS (diluted)
$1.59
$0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DX
DX
OPRX
OPRX
Q4 25
$43.5M
$32.2M
Q3 25
$30.6M
$26.1M
Q2 25
$23.1M
$29.2M
Q1 25
$17.1M
$21.9M
Q4 24
$32.3M
Q3 24
$21.3M
Q2 24
$18.8M
Q1 24
$-3.2M
$19.7M
Net Profit
DX
DX
OPRX
OPRX
Q4 25
$5.0M
Q3 25
$150.4M
$779.0K
Q2 25
$-13.6M
$1.5M
Q1 25
$-3.1M
$-2.2M
Q4 24
$-78.0K
Q3 24
$-9.1M
Q2 24
$-4.0M
Q1 24
$40.1M
$-6.9M
Gross Margin
DX
DX
OPRX
OPRX
Q4 25
74.8%
Q3 25
67.2%
Q2 25
63.8%
Q1 25
60.9%
Q4 24
68.1%
Q3 24
63.1%
Q2 24
62.2%
Q1 24
62.0%
Operating Margin
DX
DX
OPRX
OPRX
Q4 25
26.6%
Q3 25
7.9%
Q2 25
10.9%
Q1 25
-9.6%
Q4 24
11.2%
Q3 24
-40.2%
Q2 24
-19.9%
Q1 24
-25.5%
Net Margin
DX
DX
OPRX
OPRX
Q4 25
15.6%
Q3 25
491.3%
3.0%
Q2 25
-58.8%
5.2%
Q1 25
-18.0%
-10.0%
Q4 24
-0.2%
Q3 24
-42.8%
Q2 24
-21.3%
Q1 24
-1256.8%
-35.0%
EPS (diluted)
DX
DX
OPRX
OPRX
Q4 25
$1.59
$0.27
Q3 25
$1.08
$0.04
Q2 25
$-0.14
$0.08
Q1 25
$-0.06
$-0.12
Q4 24
$0.00
Q3 24
$-0.50
Q2 24
$-0.22
Q1 24
$0.64
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DX
DX
OPRX
OPRX
Cash + ST InvestmentsLiquidity on hand
$531.0M
$23.4M
Total DebtLower is stronger
$26.3M
Stockholders' EquityBook value
$2.5B
$128.3M
Total Assets
$17.3B
$176.9M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DX
DX
OPRX
OPRX
Q4 25
$531.0M
$23.4M
Q3 25
$491.0M
$19.5M
Q2 25
$387.5M
$16.6M
Q1 25
$327.4M
$16.6M
Q4 24
$13.4M
Q3 24
$16.1M
Q2 24
Q1 24
$295.7M
Total Debt
DX
DX
OPRX
OPRX
Q4 25
$26.3M
Q3 25
$28.8M
Q2 25
$29.3M
Q1 25
$33.8M
Q4 24
$34.3M
Q3 24
$36.8M
Q2 24
$37.3M
Q1 24
$37.8M
Stockholders' Equity
DX
DX
OPRX
OPRX
Q4 25
$2.5B
$128.3M
Q3 25
$2.0B
$122.3M
Q2 25
$1.6B
$119.3M
Q1 25
$1.4B
$116.3M
Q4 24
$117.0M
Q3 24
$114.5M
Q2 24
$121.0M
Q1 24
$958.5M
$122.5M
Total Assets
DX
DX
OPRX
OPRX
Q4 25
$17.3B
$176.9M
Q3 25
$14.2B
$170.3M
Q2 25
$11.3B
$169.3M
Q1 25
$9.0B
$167.8M
Q4 24
$171.2M
Q3 24
$165.2M
Q2 24
$172.9M
Q1 24
$6.3B
$176.4M
Debt / Equity
DX
DX
OPRX
OPRX
Q4 25
0.20×
Q3 25
0.24×
Q2 25
0.25×
Q1 25
0.29×
Q4 24
0.29×
Q3 24
0.32×
Q2 24
0.31×
Q1 24
0.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DX
DX
OPRX
OPRX
Operating Cash FlowLast quarter
$120.8M
$7.1M
Free Cash FlowOCF − Capex
$7.1M
FCF MarginFCF / Revenue
22.0%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
1.41×
TTM Free Cash FlowTrailing 4 quarters
$18.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DX
DX
OPRX
OPRX
Q4 25
$120.8M
$7.1M
Q3 25
$68.3M
$3.2M
Q2 25
$31.9M
$4.6M
Q1 25
$6.4M
$3.9M
Q4 24
$198.0K
Q3 24
$1.8M
Q2 24
$782.0K
Q1 24
$-17.1M
$2.1M
Free Cash Flow
DX
DX
OPRX
OPRX
Q4 25
$7.1M
Q3 25
$3.2M
Q2 25
$4.6M
Q1 25
$3.8M
Q4 24
$181.0K
Q3 24
$1.8M
Q2 24
$737.0K
Q1 24
$2.1M
FCF Margin
DX
DX
OPRX
OPRX
Q4 25
22.0%
Q3 25
12.2%
Q2 25
15.6%
Q1 25
17.5%
Q4 24
0.6%
Q3 24
8.3%
Q2 24
3.9%
Q1 24
10.6%
Capex Intensity
DX
DX
OPRX
OPRX
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.1%
Q2 24
0.2%
Q1 24
0.2%
Cash Conversion
DX
DX
OPRX
OPRX
Q4 25
1.41×
Q3 25
0.45×
4.11×
Q2 25
2.98×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
-0.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons